We are live on ! Find out more
RNAC icon

Cartesian Therapeutics
RNAC

72 hedge funds and large institutions have $86.7M invested in Cartesian Therapeutics in 2025 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 22 increasing their positions, 20 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 7

10% more repeat investments, than reductions

Existing positions increased: 22 | Existing positions reduced: 20

6% more funds holding

Funds holding: 68 → 72 (+4)

0.5% less ownership

Funds ownership: 25.91% → 25.41% (-0.5%)

27% less capital invested

Capital invested by funds: $119M → $86.7M (-$32.8M)

Holders
72
Holders Change
+4
Holders Change %
+5.88%
% of All Funds
0.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
12
Increased
22
Reduced
20
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EAM
Erste Asset Management
Austria
+$1.54M
2
Vanguard Group
Vanguard Group
Pennsylvania
+$1.32M
3
MB
MPM BioImpact
Massachusetts
+$1.24M
4
Marshall Wace
Marshall Wace
United Kingdom
+$690K
5
State Street
State Street
Massachusetts
+$509K

Top Sellers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
-$3M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$1.49M
3
JP Morgan Chase
JP Morgan Chase
New York
-$1.42M
4
N
Nuveen
North Carolina
-$790K
5
IC
Ikarian Capital
Texas
-$536K
Name Holding Trade Value Shares
Change 		Change in
Stake
AB
51
Amalgamated Bank
New York
$5K +$4.04K +226 +174%
Carson Wealth (CWM LLC)
52
Carson Wealth (CWM LLC)
Nebraska
$5K +$5.57K +312 +390%
Osaic Holdings
53
Osaic Holdings
Arizona
$1.37K -$1.18K -66 -39%
Daiwa Securities Group
54
Daiwa Securities Group
Japan
$1K – – –
AWM
55
Activest Wealth Management
Florida
$870 – – –
SWM
56
Spire Wealth Management
Virginia
$659 – – –
SS
57
SBI Securities
Japan
$646 – – –
Nisa Investment Advisors
58
Nisa Investment Advisors
Missouri
$580 -$71 -4 -8%
National Bank of Canada
59
National Bank of Canada
Quebec, Canada
$524 – – –
CCM
60
Coldstream Capital Management
Washington
$383 +$518 +29 New
SCM
61
Sterling Capital Management
North Carolina
$185 – – –
EWA
62
EverSource Wealth Advisors
Alabama
$158 +$214 +12 New
WCM
63
WealthTrak Capital Management
Virginia
$132 – – –
GI
64
GAMMA Investing
California
$119 +$161 +9 New
SIM
65
Synergy Investment Management
Florida
$79 – – –
PA
66
Parallel Advisors
California
$40 – – –
TWD
67
True Wealth Design
Ohio
$27 +$36 +2 New
IA
68
IFP Advisors
Florida
$13 – – –
BFM
69
Boothbay Fund Management
New York
– -$260K -14,491 Closed
Renaissance Technologies
70
Renaissance Technologies
New York
– -$247K -13,800 Closed
Squarepoint
71
Squarepoint
New York
– -$191K -10,652 Closed
JFGIW
72
Johnson Financial Group Inc (Wisconsin)
Wisconsin
– -$89.2K -4,618 Closed
VEA
73
Virtus ETF Advisers
New York
– -$63.3K -3,533 Closed
LJHT
74
Laurie J. Hall Trustee
– -$32K -1,759 Closed
TC
75
Truvestments Capital
Florida
– -$179 -10 Closed
1 2
3
4

RNAC Hedge Fund Activity: Q1 2025 in Review

72 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Cartesian Therapeutics (RNAC) for Q1 2025, worth a combined $86.7M — down 27% from $119M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new RNAC positions and 7 closed out — a net gain of 5 holders — while 22 added to existing stakes and 20 trimmed.

The largest buyer was Erste Asset Management, adding an estimated $1.54M. The largest seller was Citadel Advisors, cutting an estimated $3M.

  • 72 institutional investors held Cartesian Therapeutics (RNAC) as of Q1 2025, up from 68 in Q4 2024.
  • Funds reported $86.7M of Cartesian Therapeutics stock for Q1 2025, down 27% quarter-over-quarter.
  • 12 funds opened new Cartesian Therapeutics positions in Q1 2025 and 7 closed out, a net change of +5 holders.
  • The largest Cartesian Therapeutics buyer in Q1 2025 was Erste Asset Management, an estimated $1.54M added.
  • The largest Cartesian Therapeutics seller in Q1 2025 was Citadel Advisors, an estimated $3M sold.

Based on aggregated 13F filings for Q1 2025.